These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12823400)

  • 21. The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.
    Song K; Choo MS; Lee KS; Han JY; Lee YS; Kim JC; Cho JS
    Urology; 2011 May; 77(5):1177-82. PubMed ID: 21256567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
    Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
    J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of treatment response to drugs in benign prostatic hyperplasia.
    Wein AJ
    Urol Clin North Am; 1990 Aug; 17(3):631-40. PubMed ID: 1695783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.
    Caine M; Perlberg S; Meretyk S
    Br J Urol; 1978 Dec; 50(7):551-4. PubMed ID: 88984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of alpha-blockers for the treatment of symptomatic BPH.
    de Mey C
    Eur Urol; 1998; 34 Suppl 2():18-28; discusion 47. PubMed ID: 9732829
    [No Abstract]   [Full Text] [Related]  

  • 26. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
    Sakr M; Eid A; Shoukry M; Fayed A
    Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effectiveness of beta-sitosterol in treatment of benign prostatic hyperplasia].
    Senge T; Windeler J; Berges RR; Trampisch HJ
    Urologe A; 1995 Mar; 34(2):130-1. PubMed ID: 7538710
    [No Abstract]   [Full Text] [Related]  

  • 28. [Urodynamic study of lower urinary tract. VI. Clinical application of alpha adrenergic blocker for the treatment of benign prostatic hypertrophy and bladder neck contracture (author's transl)].
    Kondo A; Narita H; Otani T; Kobayashi M; Takita T
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1232-40. PubMed ID: 83419
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of benign prostatic hyperplasia with phytosterols.
    Carbin BE; Larsson B; Lindahl O
    Br J Urol; 1990 Dec; 66(6):639-41. PubMed ID: 1702340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bipolar transurethral resection in saline--an alternative surgical treatment for bladder outlet obstruction?
    Michielsen DP; Debacker T; De Boe V; Van Lersberghe C; Kaufman L; Braeckman JG; Amy JJ; Keuppens FI
    J Urol; 2007 Nov; 178(5):2035-9; discussion 2039. PubMed ID: 17869297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 32. EFFICACY OF SILODOSIN (UROREC®) IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: THE MAXIMUM DECREASE OF BLADDER OUTLET OBSTRUCTION INDEX.
    Khamzin A; Frolov R
    Georgian Med News; 2018 Mar; (276):18-23. PubMed ID: 29697376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Male lower urinary tract symptoms and sildenafil.
    Jackson G
    Int J Clin Pract; 2007 Nov; 61(11):1779. PubMed ID: 17935539
    [No Abstract]   [Full Text] [Related]  

  • 34. Injectables in the prostate.
    Saemi AM; Plante MK
    Curr Opin Urol; 2008 Jan; 18(1):28-33. PubMed ID: 18090486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 36. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 37. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hormonal therapy of benign prostatic hyperplasia].
    Horninger W; Bartsch G
    Urologe A; 1995 Jan; 34(1):9-15. PubMed ID: 7533450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Getting ready for certification: urinary tract inflammation and disease.
    Linn MM
    Urol Nurs; 2007 Aug; 27(4):324-5. PubMed ID: 17877104
    [No Abstract]   [Full Text] [Related]  

  • 40. Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia.
    Tammela TL; Kontturi MJ
    J Urol; 1993 Feb; 149(2):342-4. PubMed ID: 7678871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.